{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T02:49:10Z","timestamp":1773110950787,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T00:00:00Z","timestamp":1683849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T00:00:00Z","timestamp":1683849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["No.2016SZ0058"],"award-info":[{"award-number":["No.2016SZ0058"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["No.23ZDYF2920"],"award-info":[{"award-number":["No.23ZDYF2920"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Giant prolactinoma (&gt;\u20094\u00a0cm in dimension) is a rare disorder. Invasive macroprolactinoma has the potential to cause base of skull erosion and extend into the nasal cavity or even the sphenoid sinus. Nasal bleeding caused by intranasal tumor extension is a rare complication associated with invasive giant prolactinoma.<\/jats:p><jats:p>We report a case of giant invasive macroprolactinoma with repeated nasal bleeding as the initial symptom.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>A 24-year-old man with an invasive giant prolactinoma in the nasal cavity and sellar region who presented with nasal bleeding as the initial symptom, misdiagnosed as olfactory neuroblastoma. However, markedly elevated serum prolactin levels (4700\u00a0ng\/mL), and a 7.8-cm invasive sellar mass confirmed the diagnosis of invasive giant prolactinoma. He was treated with oral bromocriptine. Serum prolactin was reduced to near normal after 6\u00a0months of treatment. Follow-up magnetic resonance imaging showed that the sellar lesion had disappeared completely and the skull base lesions were reduced.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This case is notable in demonstrating the aggressive nature of untreated invasive giant prolactinomas which can cause a diagnostic difficulty with potential serious consequences. Early detection of hormonal levels can avoid unnecessary nasal biopsy. Early identification of pituitary adenoma with nasal bleeding as the first symptom is particularly important.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12902-023-01345-y","type":"journal-article","created":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T05:01:56Z","timestamp":1683867716000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A giant invasive macroprolactinoma with recurrent nasal bleeding as the first clinical presentation: case report and review of literature"],"prefix":"10.1186","volume":"23","author":[{"given":"Danting","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0451-8283","authenticated-orcid":false,"given":"Huiwen","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peiqiong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yerong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,12]]},"reference":[{"issue":"8","key":"1345_CR1","first-page":"e9763","volume":"12","author":"MM Blackmon","year":"2020","unstructured":"Blackmon MM, Gilbert AR, Floyd J, Hafeez S, Seifi A. Lost to follow-up: complications of an invasive giant prolactinoma. Cureus. 2020;12(8):e9763.","journal-title":"Cureus"},{"issue":"2","key":"1345_CR2","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3171\/jns.2002.97.2.0299","volume":"97","author":"RK Shrivastava","year":"2002","unstructured":"Shrivastava RK, Arginteanu MS, King WA, Post KD. Giant prolactinomas: clinical management and long-term follow up. J Neurosurg. 2002;97(2):299\u2013306.","journal-title":"J Neurosurg"},{"issue":"5","key":"1345_CR3","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1046\/j.1365-2265.2003.01770.x","volume":"58","author":"SM Corsello","year":"2003","unstructured":"Corsello SM, Ubertini G, Altomare M, Lovicu RM, Migneco MG, Rota CA, Colosimo C. Giant prolactinomas in men: efficacy of cabergoline treatment. Clin Endocrinol (Oxf). 2003;58(5):662\u201370.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"1345_CR4","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1055\/a-0752-0741","volume":"50","author":"P Iglesias","year":"2018","unstructured":"Iglesias P, Arcano K, Berrocal VR, Bernal C, Villabona C, Diez JJ. Giant prolactinoma in men: clinical features and therapeutic outcomes. Horm Metab Res. 2018;50(11):791\u20136.","journal-title":"Horm Metab Res"},{"issue":"4","key":"1345_CR5","doi-asserted-by":"publisher","first-page":"340","DOI":"10.4158\/EP-2018-0392","volume":"25","author":"O Hamidi","year":"2019","unstructured":"Hamidi O, Van Gompel J, Gruber L, Kittah NE, Donegan D, Philbrick KA, Koeller KK, Erickson D, Natt N, Nippoldt TB, Young WF Jr, Bancos I. Management and outcomes of giant prolactinoma: a series of 71 patients. Endocr Pract. 2019;25(4):340\u201352.","journal-title":"Endocr Pract"},{"issue":"3","key":"1345_CR6","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s11102-013-0497-x","volume":"17","author":"I Shimon","year":"2014","unstructured":"Shimon I, Benbassat C. Male prolactinomas presenting with normal testosterone levels. Pituitary. 2014;17(3):246\u201350.","journal-title":"Pituitary"},{"issue":"12","key":"1345_CR7","doi-asserted-by":"publisher","first-page":"4721","DOI":"10.1210\/jc.2007-2758","volume":"93","author":"M Ono","year":"2008","unstructured":"Ono M, Miki N, Kawamata T, Makino R, Amano K, Seki T, Kubo O, Hori T, Takano K. Prospective study of high-dose cabergoline treatment of prolactinomas in 150 patients. J Clin Endocrinol Metab. 2008;93(12):4721\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1345_CR8","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1023\/A:1025377816769","volume":"5","author":"L Sibal","year":"2002","unstructured":"Sibal L, Ugwu P, Kendall-Taylor P, Ball SG, James RA, Pearce SH, Hall K, Quinton R. Medical therapy of macroprolactinomas in males: I. Prevalence of hypopituitarism at diagnosis. II. Proportion of cases exhibiting recovery of pituitary function. Pituitary. 2002;5(4):243\u20136.","journal-title":"Pituitary."},{"issue":"8 Pt 1","key":"1345_CR9","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1177\/000348948909800810","volume":"98","author":"AG van der Mey","year":"1989","unstructured":"van der Mey AG, van Seters AP, van Krieken JH, Vielvoye J, van Dulken H, Hulshof JH. Large pituitary adenomas with extension into the nasopharynx. Report of three cases with a review of the literature. Ann Otol Rhinol Laryngol. 1989;98(8 Pt 1):618\u201324.","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"5","key":"1345_CR10","first-page":"227","volume":"68","author":"R Hofman","year":"2010","unstructured":"Hofman R, Franken AA, Rosingh HJ. Just epistaxis? Neth J Med. 2010;68(5):227\u201330.","journal-title":"Neth J Med"},{"issue":"2","key":"1345_CR11","doi-asserted-by":"crossref","first-page":"134","DOI":"10.4103\/1817-1745.92840","volume":"6","author":"PK Chaurasia","year":"2011","unstructured":"Chaurasia PK, Singh D, Meher S, Saran RK, Singh H. Epistaxis as first clinical presentation in a child with giant prolactinoma: case report and review of literature. J Pediatr Neurosci. 2011;6(2):134\u20137.","journal-title":"J Pediatr Neurosci"},{"key":"1345_CR12","doi-asserted-by":"publisher","first-page":"bcr2014208811","DOI":"10.1136\/bcr-2014-208811","volume":"2015","author":"JP Sahoo","year":"2015","unstructured":"Sahoo JP, Kamalanathan S, Parida PK, Pillai V. A giant prolactinoma with nasopharyngeal extension presenting with nasal blockage and epistaxis. BMJ Case Rep. 2015;2015:bcr2014208811.","journal-title":"BMJ Case Rep."},{"issue":"10","key":"1345_CR13","doi-asserted-by":"publisher","first-page":"654","DOI":"10.2176\/nmc.38.654","volume":"38","author":"J Imamura","year":"1998","unstructured":"Imamura J, Okuzono T, Okuzono Y. Fatal epistaxis caused by rupture of an intratumoral aneurysm enclosed by a large prolactinoma\u2013case report. Neurol Med Chir (Tokyo). 1998;38(10):654\u20136.","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"12","key":"1345_CR14","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1017\/S0022215100158037","volume":"113","author":"B Godey","year":"1999","unstructured":"Godey B, Morandi X, Le Gall F, Feat S, Brassier G, Le Clech G. Pituitary adenomas with infra-sellar extension into the nasopharynx. J Laryngol Otol. 1999;113(12):1109\u201311.","journal-title":"J Laryngol Otol"},{"issue":"11","key":"1345_CR15","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/S0046-8177(98)90254-4","volume":"29","author":"BK Kleinschmidt-DeMasters","year":"1998","unstructured":"Kleinschmidt-DeMasters BK, Lillehei KO. Pathological correlates of pituitary adenomas presenting with apoplexy. Hum Pathol. 1998;29(11):1255\u201365.","journal-title":"Hum Pathol"},{"issue":"6","key":"1345_CR16","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/BF03343584","volume":"22","author":"NN Ghannam","year":"1999","unstructured":"Ghannam NN, Hammami MM, Muttair Z, Bakheet SM. Primary hypothyroidism-associated TSH-secreting pituitary adenoma\/hyperplasia presenting as a bleeding nasal mass and extremely elevated TSH level. J Endocrinol Invest. 1999;22(6):419\u201323.","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"1345_CR17","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.2214\/AJR.05.0329","volume":"186","author":"CJ Das","year":"2006","unstructured":"Das CJ, Seith A, Gamanagatti S, Goswami R. On the AJR viewbox. Ectopic pituitary adenoma with an empty sella. AJR Am J Roentgenol. 2006;186(5):1468\u20139.","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"1345_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1159\/000499694","volume":"109","author":"L Vilar","year":"2019","unstructured":"Vilar L, Vilar CF, Lyra R, Freitas MDC. Pitfalls in the diagnostic evaluation of hyperprolactinemia. Neuroendocrinology. 2019;109(1):7\u201319.","journal-title":"Neuroendocrinology"},{"issue":"4","key":"1345_CR19","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s11102-022-01246-8","volume":"25","author":"V Raverot","year":"2022","unstructured":"Raverot V, Perrin P, Chanson P, Jouanneau E, Brue T, Raverot G. Prolactin immunoassay: does the high-dose hook effect still exist? Pituitary. 2022;25(4):653\u20137.","journal-title":"Pituitary"},{"issue":"2","key":"1345_CR20","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/s12020-018-1702-5","volume":"62","author":"HY Huang","year":"2018","unstructured":"Huang HY, Zhai W, Tang H, Hui GZ, Wu ZB. Cabergoline for the treatment of bromocriptine-resistant invasive giant prolactinomas. Endocrine. 2018;62(2):464\u20139.","journal-title":"Endocrine"},{"issue":"2","key":"1345_CR21","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3390\/cancers12020514","volume":"12","author":"J Trouillas","year":"2020","unstructured":"Trouillas J, Jaffrain-Rea ML, Vasiljevic A, Raverot G, Roncaroli F, Villa C. How to Classify the Pituitary Neuroendocrine Tumors (PitNET)s in 2020. Cancers (Basel). 2020;12(2):514.","journal-title":"Cancers (Basel)"},{"issue":"4","key":"1345_CR22","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/PAS.0000000000000784","volume":"41","author":"MD Hyrcza","year":"2017","unstructured":"Hyrcza MD, Ezzat S, Mete O, Asa SL. Pituitary adenomas presenting as sinonasal or nasopharyngeal masses: a case series illustrating potential diagnostic pitfalls. Am J Surg Pathol. 2017;41(4):525\u201334.","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"1345_CR23","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1210\/jcem.74.4.1548346","volume":"74","author":"AJ van der Lely","year":"1992","unstructured":"van der Lely AJ, Knegt PP, Stefanko SZ, Tanghe HL, Singh R, Lamberts SW. Nasopharyngeal presentation of pituitary tumors. Differential diagnosis and treatment. J Clin Endocrinol Metab. 1992;74(4):811\u20133.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1345_CR24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000495184","volume":"109","author":"I Shimon","year":"2019","unstructured":"Shimon I. Giant Prolactinomas. Neuroendocrinology. 2019;109(1):51\u20136.","journal-title":"Neuroendocrinology"},{"issue":"3","key":"1345_CR25","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1210\/clinem\/dgz144","volume":"105","author":"AH ZamanipoorNajafabadi","year":"2020","unstructured":"ZamanipoorNajafabadi AH, Zandbergen IM, de Vries F, Broersen LHA, van den Akker-van Marle ME, Pereira AM, Peul WC, Dekkers OM, van Furth WR, Biermasz NR. Surgery as a viable alternative first-line treatment for prolactinoma patients a systematic review and meta-analysis. J Clin Endocrinol Metab. 2020;105(3):e32-41.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1345_CR26","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1530\/EJE-06-0646","volume":"156","author":"I Shimon","year":"2007","unstructured":"Shimon I, Benbassat C, Hadani M. Effectiveness of long-term cabergoline treatment for giant prolactinoma: study of 12 men. Eur J Endocrinol. 2007;156(2):225\u201331.","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"1345_CR27","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/cen.12242","volume":"79","author":"AB Moraes","year":"2013","unstructured":"Moraes AB, Silva CM, Vieira Neto L, Gadelha MR. Giant prolactinomas: the therapeutic approach. Clin Endocrinol (Oxf). 2013;79(4):447\u201356.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"1345_CR28","doi-asserted-by":"publisher","first-page":"R213","DOI":"10.1530\/EJE-14-0013","volume":"170","author":"D Maiter","year":"2014","unstructured":"Maiter D, Delgrange E. Therapy of endocrine disease: the challenges in managing giant prolactinomas. Eur J Endocrinol. 2014;170(6):R213-227.","journal-title":"Eur J Endocrinol"},{"key":"1345_CR29","doi-asserted-by":"publisher","first-page":"768","DOI":"10.3389\/fendo.2018.00768","volume":"9","author":"X Liu","year":"2018","unstructured":"Liu X, Tang C, Wen G, Zhong C, Yang J, Zhu J, Ma C. The mechanism and pathways of dopamine and dopamine agonists in prolactinomas. Front Endocrinol. 2018;9:768.","journal-title":"Front Endocrinol"},{"key":"1345_CR30","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.clineuro.2014.02.028","volume":"120","author":"K Aslan","year":"2014","unstructured":"Aslan K, Bekci T, Incesu L, \u00d6zdemir M. Giant invasive basal skull prolactinoma with CSF rhinorrhoea and meningitis. Clin Neurol Neurosurg. 2014;120:145\u20136.","journal-title":"Clin Neurol Neurosurg"},{"issue":"12","key":"1345_CR31","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/j.jocn.2013.02.027","volume":"20","author":"E Chng","year":"2013","unstructured":"Chng E, Dalan R. Pituitary apoplexy associated with cabergoline therapy. J Clin Neurosci. 2013;20(12):1637\u201343.","journal-title":"J Clin Neurosci"},{"issue":"6","key":"1345_CR32","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s11102-018-0907-1","volume":"21","author":"T Cesak","year":"2018","unstructured":"Cesak T, Poczos P, Adamkov J, Nahlovsky J, Kasparova P, Gabalec F, Celakovsky P, Choutka O. Medically induced CSF rhinorrhea following treatment of macroprolactinoma: case series and literature review. Pituitary. 2018;21(6):561\u201370.","journal-title":"Pituitary"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-023-01345-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-023-01345-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-023-01345-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,20]],"date-time":"2024-10-20T07:34:02Z","timestamp":1729409642000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-023-01345-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,12]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1345"],"URL":"https:\/\/doi.org\/10.1186\/s12902-023-01345-y","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,12]]},"assertion":[{"value":"22 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our study was approved by the Ethics Committee of West China Hospital of Sichuan University. The clinical research was implemented according to the principles expressed in the World Medical Association Declaration of Helsinki and the International Ethical Guidelines for Biomedical Research Involving Subjects (GIOMS, Geneva, 1993).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for the publication of any potentially identifiable images or data included in this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"107"}}